Exane Derivatives’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $92K | Hold |
9,496
| – | – | 0.05% | 271 |
|
|
2022
Q1 | $94.4K | Sell |
9,496
-811
| -8% | -$8.06K | 0.03% | 479 |
|
|
2021
Q4 | $121K | Sell |
10,307
-466
| -4% | -$5.49K | 0.03% | 419 |
|
|
2021
Q3 | $123K | Buy |
10,773
+1,268
| +13% | +$14.4K | 0.03% | 484 |
|
|
2021
Q2 | $131K | Buy |
9,505
+2,941
| +45% | +$40.6K | 0.03% | 501 |
|
|
2021
Q1 | $121K | Sell |
6,564
-1,299
| -17% | -$24K | 0.03% | 383 |
|
|
2020
Q4 | $139K | Buy |
7,863
+2,580
| +49% | +$45.6K | 0.04% | 342 |
|
|
2020
Q3 | $80.9K | Buy |
5,283
+1,033
| +24% | +$15.8K | 0.02% | 319 |
|
|
2020
Q2 | $108K | Sell |
4,250
-1,640
| -28% | -$41.8K | 0.03% | 264 |
|
|
2020
Q1 | $91.2K | Buy |
+5,890
| New | +$91.2K | 0.03% | 274 |
|